Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5245]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Young SIOG attendees and and the latest CDK inhibitors research in breast cancer
Nicolò Battisti - The Royal Marsden NHS Foundation Trust, London, UK
Young SIOG attendees and and the latest CDK inhibitors research in breast cancer ( Nicolò Battisti - The Royal Marsden NHS Foundation Trust, London, UK )
22 Nov 2018
Brain metastases: therapeutic options
Prof Brigette Dréno - University Hospital Nantes, Nantes, France
Brain metastases: therapeutic options ( Prof Brigette Dréno - University Hospital Nantes, Nantes, France )
22 Nov 2018
BRAF/MEK inhibition as adjuvant treatment in melanoma
Dr Jessica Hassel - Heidelberg University Hospital, Heidelberg, Germany
BRAF/MEK inhibition as adjuvant treatment in melanoma ( Dr Jessica Hassel - Heidelberg University Hospital, Heidelberg, Germany )
22 Nov 2018
The changing landscape of melanoma treatment
Dr Eva Muñoz-Couselo - University Hospital Vall d'Hebron
The changing landscape of melanoma treatment ( Dr Eva Muñoz-Couselo - University Hospital Vall d'Hebron )
22 Nov 2018
Breast cancer highlights from ESMO 2018
Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium
Breast cancer highlights from ESMO 2018 ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )
12 Nov 2018
Editor’s Choice for October 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for October 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
1 Nov 2018
The IMpower-132 trial for non small cell lung cancer
Dr Vassiliki Papadimitrakopoulou - University of Texas MD Anderson Cancer...
The IMpower-132 trial for non small cell lung cancer ( Dr Vassiliki Papadimitrakopoulou - University of Texas MD Anderson Cancer Center, Houston, US )
29 Oct 2018
ILLUMINATE 301: ipilimumab versus IMO-2125 combined with ipilimumab in anti PD...
Prof Paolo Ascierto - Istituto Nazionale Tumori, Milan, Italy
ILLUMINATE 301: ipilimumab versus IMO-2125 combined with ipilimumab in anti PD 1 refractory melanoma ( Prof Paolo Ascierto - Istituto Nazionale Tumori, Milan, Italy )
29 Oct 2018
Keynote lecture: Mutation signatures and targeting the DNA damage response
Prof Thomas Helleday - Sheffield Cancer Centre, Sheffield, UK
Keynote lecture: Mutation signatures and targeting the DNA damage response ( Prof Thomas Helleday - Sheffield Cancer Centre, Sheffield, UK )
29 Oct 2018
Dosing regiment in the combination of ipilimumab and nivolumab in stage III...
Dr Lisette Rozeman - Netherlands Cancer Institute, Amsterdam, Netherlands
Dosing regiment in the combination of ipilimumab and nivolumab in stage III melanoma ( Dr Lisette Rozeman - Netherlands Cancer Institute, Amsterdam, Netherlands )
29 Oct 2018
COLUMBUS: Encorafenib plus binimetinib versus vemurafenib or encorafenib in...
Prof Dirk Schadendorf - Uniklinik Essen, Essen, Germany
COLUMBUS: Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma ( Prof Dirk Schadendorf - Uniklinik Essen, Essen, Germany )
29 Oct 2018
Modern melanoma treatment in the UK
Dr Joseph Sacco - University of Liverpool, Liverpool, UK
Modern melanoma treatment in the UK ( Dr Joseph Sacco - University of Liverpool, Liverpool, UK )
26 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation